We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Development of Self-Regulation in Individuals With Type 2 Diabetes

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00941447
First Posted: July 17, 2009
Last Update Posted: May 5, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Abbott Diabetes Care
Information provided by:
University of Tennessee
July 15, 2009
July 17, 2009
May 5, 2011
April 2009
February 2011   (Final data collection date for primary outcome measure)
Blood Glucose [ Time Frame: 12 weeks ]
Same as current
Complete list of historical versions of study NCT00941447 on ClinicalTrials.gov Archive Site
  • Caloric, fat and carbohydrate intake [ Time Frame: 12 weeks ]
  • Self-efficacy [ Time Frame: 12-weeks ]
  • Self-management activities [ Time Frame: 12 weeks ]
  • Physical activities [ Time Frame: 12 weeks ]
  • Quality of Life [ Time Frame: 12 weeks ]
Same as current
Not Provided
Not Provided
 
Development of Self-Regulation in Individuals With Type 2 Diabetes
Not Provided
The purpose of this investigation is to conduct a 12-week study to compare the effects of a self-regulation intervention (SR), in which participants will self-monitor their blood glucose (BG) and adjust dietary intake and physical activity through the use of current dietary and physical activity guidelines to help regulate their BG, to an education and self-monitoring only intervention (SM), on blood glucose, self-efficacy, and diabetes self-management activities.

As our nation continues to battle overweight and obesity, the prevalence of diabetes will precipitously increase, placing additional financial burden on our country. Therefore, finding ways to manage this chronic disease is essential. While self-monitoring of blood glucose (SMBG) has been shown to be effective in improving glycemic control in individuals with type 1 diabetes, the importance of encouraging individuals with type 2 diabetes to engage in SMBG for better blood glucose (BG) is still unclear. SMBG is believed to be key in the self-management of diabetes, as it can provide feedback on dietary and activity behaviors that are believed to impact on BG. The use of SMBG to adjust other behaviors that impact on BG is a self-regulatory approach to diabetes management. Self-regulation of BG is theorized to impact on self-efficacy in the management of diabetes. Through greater self-efficacy, greater compliance to diabetes self-management behaviors is achieved. Currently, no trial has examined the use of a self-regulation approach using current dietary and physical activity recommendations for individuals with type 2 diabetes who are not on insulin.

Thus, this investigation will involve a 12-week study to examine the effect of an SR intervention to SM intervention. All participants in the investigation will receive a standard 12-week behavioral intervention. The intervention will include a reduced caloric prescription (1200-1500 kcal/day), fat gram prescription (30% or less kcals from fat), carbohydrate gram prescription (150-190 grams/day) and a physical activity goal (slowly building up to 150minutes/week of moderate-intense physical activity at the end of study).

Participants will be assessed at 0 and 13 weeks (pre- and post-intervention) on measures of fasting blood glucose, self-efficacy, and diabetes self-management activities. Additionally, dietary intake, physical activity, quality of life and body weight measurements will be taken at 0 and 13 weeks for comparisons between the two treatment groups.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Type 2 Diabetes
  • Behavioral: Dietary
    All participants in the investigation will receive a standard 12-week behavioral intervention with seven 30-45 minute phone interventions and education sessions. The intervention includes a reduced caloric prescription (1200-1500 kcal/day),fat gram prescription (30% or less kcals from fat) and carbohydrate gram prescription (150-190 grams).
  • Behavioral: Physical Activity
    There is a physical Activity of 150 minutes/week of moderate-intense physical activity.
  • Behavioral: Self-Regulatory Approaches
    Participants in this arm will receive extensive feedback based on their self-monitoring diary in which the researcher will be reinforced in areas that they are doing well in regarding their blood glucose and also assist in problem solving in areas that need improvement.
  • Experimental: Self-Regulation
    Self Regulation Arm focuses on increasing participants self-monitoring blood glucose (SMBG) AND awareness of self-regulatory approaches to managing diabetes.
    Interventions:
    • Behavioral: Dietary
    • Behavioral: Physical Activity
    • Behavioral: Self-Regulatory Approaches
  • Experimental: Self-Monitoring
    Self-Monitoring Arm focuses on increasing participants self-monitoring blood glucose (SMBG) and providing nutrition education ONLY.
    Interventions:
    • Behavioral: Dietary
    • Behavioral: Physical Activity
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
25
February 2011
February 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Recruitment from Cherokee Health Systems, Healthy Eating and Activity Laboratory Ineligible Database, UTK faculty and staff, and local endocrinologists' offices.
  • Have been diagnosed with Type 2 diabetes for a minimum of 1 year.
  • Fasting BG of ≥ 126mg/dl6.
  • Between the age of 21 and 65 years. Older adults may have more medical co-morbidities and may require greater medical supervision29.
  • Considered overweight or obese by the body mass index (BMI). BMI between 27 and 45 kg/m2 29. The American Diabetes Association 2008 position statement for current nutrition recommendations and interventions for diabetes encourages those individuals within this BMI range to follow the low-calorie, low-fat diet that is prescribed in both conditions in this investigation6.
  • Not treated with insulin.
  • Are taking medicine that do not typically cause hypoglycemia: Refer to diabetes medication list in Appendices Ai-Aii.
  • Willing to increase physical activity to 150mins/week in 3 months.
  • Willing to be randomized to either condition.
  • Able to report that they can read and understand English.
  • Able to report that they can keep a food diary and perform basic mathematics.

Exclusion Criteria:

  • Report a heart condition, chest pain during periods of activity or rest or loss of consciousness on the Physical Activity Readiness Questionnaire (PAR-Q). Individuals self-reporting joint problems, prescription medication usage related to heart conditions, or other medical conditions that could limit exercise will be required to obtain written physician consent to participate.
  • Report being unable to walk for 2 blocks (1/4 mile) without stopping.
  • Report major psychiatric diseases.
  • Are compliant with dietary and physical activity recommendations to achieve ideal body weight.
  • Taking any weight loss medication.
  • Pregnant, expecting to be pregnant and/or lactating.
  • Have no working phone.
  • Are unwilling to participate in phone calls that are a part of the condition that in which they have been randomized.
Sexes Eligible for Study: All
21 Years to 65 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00941447
3R01DK074721( U.S. NIH Grant/Contract )
No
Not Provided
Not Provided
Lusi M Martin, MS-MPH Graduate Student, University of Tennessee, Knoxville
University of Tennessee
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Abbott Diabetes Care
Principal Investigator: Lusi M Martin, BA University of Tennessee, Knoxville
Study Chair: Hollie A Raynor, Ph.D University of Tennessee, Knoxville
University of Tennessee
May 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP